PharmacyCodes



Halofantrinum [Inn-Latin] en es it fr

Halofantrinum [Inn-Latin] Brand names, Halofantrinum [Inn-Latin] Analogs

Halofantrinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Halofantrinum [Inn-Latin] Chemical_Formula

C26H30Cl2F3NO

Halofantrinum [Inn-Latin] RX_link

No information avaliable

Halofantrinum [Inn-Latin] fda sheet

Halofantrinum_[Inn-Latin] FDA

Halofantrinum [Inn-Latin] msds (material safety sheet)

Halofantrinum_[Inn-Latin] MSDS

Halofantrinum [Inn-Latin] Synthesis Reference

idem, U.S. patent 4507288 (1985 to Smithkline Beckman)

Halofantrinum [Inn-Latin] Molecular Weight

500.423 g/mol

Halofantrinum [Inn-Latin] Melting Point

No information avaliable

Halofantrinum [Inn-Latin] H2O Solubility

No information avaliable

Halofantrinum [Inn-Latin] State

Solid

Halofantrinum [Inn-Latin] LogP

9.199

Halofantrinum [Inn-Latin] Dosage Forms

Tablet

Halofantrinum [Inn-Latin] Indication

For treatment of Severe malaria

Halofantrinum [Inn-Latin] Pharmacology

Halofantrine is a synthetic antimalarial which acts as a blood schizonticide. It is effective against multi drug resistant (including mefloquine resistant) P. falciparum malaria.

Halofantrinum [Inn-Latin] Absorption

No information avaliable

Halofantrinum [Inn-Latin] side effects and Toxicity

Side effects incldue coughing noisy, rattling, troubled breathing, loss of appetite, aches and pain in joints, indigestion,and skin itching or rash.

Halofantrinum [Inn-Latin] Patient Information

No information avaliable

Halofantrinum [Inn-Latin] Organisms Affected

Plasmodium